Ruta graveolens,a Homoeopathic medicine in the treatment of Colorectal cancer
- Conditions
- Health Condition 1: C20- Malignant neoplasm of rectum
- Registration Number
- CTRI/2024/05/067749
- Lead Sponsor
- ational Institute Of Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients of all genders, different religions and socioeconomic groups.
Age between 18-80 years.
Histologically confirmed Colorectal cancer patients.
In case the medicine does not provide relief or aggravate the patients condition and the
disease progresses further, immediate care will be taken by providing the proper dose of medicine
Patients having Colorectal Malignancy of any histological type at any stage except
those mentioned under exclusion.
Patients who are otherwise untreated and have opted for homoeopathic treatment.
Patients who have already had Surgery, Radiotherapy or Chemotherapy but now intend
to undergo homoeopathic treatment.
Patient willing to give written consent for participating in the study and complete
follow-up during study.
Patients who continue to be under Chemotherapy or Radiotherapy.
Pregnant and Lactating women.
Patients not willing to undergo any investigation, even after advised.
Individuals unwilling to get solely homoeopathic treatment.
Patients in the terminal stage of illness.
Diagnosed cases of unstable mental or psychiatric illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor biomarker CEA will be evaluated <br/ ><br>Timepoint: At baseline, after 3 months and 6 months of treatment
- Secondary Outcome Measures
Name Time Method The response of the patients will be observed and improvement in Quality of Life will be <br/ ><br>assessed with EORTC QLQ-CR29 scaleTimepoint: at baseline, <br/ ><br>after 3 months & 6 months of treatment